EV/EBITDA - Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) - Alpha Spread
F

Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436

Watchlist Manager
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Watchlist
Price: 18.43 CNY -1.34% Market Closed
Market Cap: 2.9B CNY
Have any thoughts about
Fujian Cosunter Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-22.3
Current
-26.3
Median
13.4
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-22.3
=
Enterprise Value
3.1B CNY
/
EBITDA
-139.7m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More